Although no significant associations were observed between liver fibrosis and the TM6SF2, GCKR, or HSD17B13 polymorphisms in our cohort, these variants have been reported to influence MASLD susceptibility in other populations. This evidence concerns the gene HSD17B13 and Hepatic fibrosis.